Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO

Stock Track

04/18

Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.

The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.

Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1176686851"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176686851\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176686851?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-18 00:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176686851","market":"nz","top_or_hot":-1,"title":"Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO","media":"Stock Track","content":"<p>Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.</p><p>The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.</p><p>Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-04-18 00:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.</p><p>The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.</p><p>Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALMR","symbol_name":"Alamar Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1176686851","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176686851","pubTimestamp":1776443855,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.The proteomics company, which develops instruments to detect...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALMR":"Alamar Biosciences, Inc."},"translate_title":"个股赛道|Alamar Biosciences在扩大IPO规模后在纳斯达克首次亮相表现强劲，盘中飙升32.94%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALMR":1},"content_text":"Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}